Uppsala's 'smart' robot tests new cancer drug combos

Researchers at Uppsala University in Sweden have developed a robot that can assess various combination therapies for cancer, analyzing the results and flagging their potential as new therapies. "We have built a robot system that plans and conducts experiments with many substances, and draws its own conclusions from the results," said Dr. Claes Andersson, a leading scientist on the project, in a release. "The idea is to gradually refine combinations of substances so that they kill cancer cells without harming healthy cells." Release

Suggested Articles

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.